Compare SND & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SND | KRRO |
|---|---|---|
| Founded | 2011 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Mining & Quarrying of Nonmetallic Minerals (No Fuels) | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 99.3M | 101.1M |
| IPO Year | 2016 | 2019 |
| Metric | SND | KRRO |
|---|---|---|
| Price | $5.35 | $11.22 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 12 |
| Target Price | N/A | ★ $54.60 |
| AVG Volume (30 Days) | ★ 412.6K | 291.1K |
| Earning Date | 03-02-2026 | 03-17-2026 |
| Dividend Yield | ★ 2.80% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.10 | N/A |
| Revenue | ★ $335,471,000.00 | $7,371,000.00 |
| Revenue This Year | N/A | $145.97 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $53.67 | ★ N/A |
| Revenue Growth | ★ 18.98 | N/A |
| 52 Week Low | $1.76 | $5.20 |
| 52 Week High | $5.39 | $55.89 |
| Indicator | SND | KRRO |
|---|---|---|
| Relative Strength Index (RSI) | 64.77 | 54.35 |
| Support Level | $4.64 | $10.81 |
| Resistance Level | $5.04 | $12.46 |
| Average True Range (ATR) | 0.26 | 1.08 |
| MACD | -0.00 | -0.05 |
| Stochastic Oscillator | 77.97 | 33.02 |
Smart Sand Inc. is a fully integrated frac sand company providing mine-to-well site proppant supply and logistics. It produces Northern White frac sand for enhanced hydrocarbon recovery in oil and gas wells. The company offers products like Smart System, SmartBelt, SmartDepot Silo, and SmartPath Loader. It is expanding into industrial markets, including glass, ceramics, and renewable energy, while its main revenue comes from sand sales and logistics.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.